Loading...
Pioglitazone vs. Glimepiride on Coronary Artery Calcium Progression in Type 2 Diabetes: A Secondary Endpoint of the CHICAGO Study
OBJECTIVE: The CHICAGO (Carotid Intima-Media Thickness in Atherosclerosis Using Pioglitazone) study demonstrated that pioglitazone (PIO) significantly decreased Carotid Intimal Media Thickness (CIMT) progression compared to glimepiride (GLM) in patients with Type 2 diabetes mellitus (T2DM). A second...
Na minha lista:
| Main Authors: | , , , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
2010
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2945383/ https://ncbi.nlm.nih.gov/pubmed/20576945 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/ATVBAHA.110.207696 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|